Publications
16
Citations
25
Est. group size
~5
Recurring co-author estimate
Active years
7
Publishing since 2020
Quinn Kistenfeger's work focuses on gynecologic cancers, particularly ovarian and cervical cancer, including treatment approaches such as PARP inhibitor drugs (a class of targeted cancer therapy) and management of treatment-related complications like low white blood cell counts (neutropenia). The research also touches on related clinical topics such as gynecologic infections and ethical considerations in clinical research. This work is clinically oriented, aimed at informing patient care and treatment decisions in gynecologic oncology.
Publication activity was minimal or absent for most of the past decade but increased sharply starting in 2023-2024, suggesting a recent growth phase.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Patient Selection for the Use of Niraparib in Advanced Ovarian Cancer: A Review
International Journal of Women s Health · 2024
- Assessment of the therapeutic use of myeloid growth factors in the treatment of patients with febrile neutropenia and gynecologic malignancies
Gynecologic Oncology · 2024
- Hydronephrosis Due to Bilateral Tubo-ovarian Abscess
Clinical Practice and Cases in Emergency Medicine · 2020
- Gynecologic Oncology×9
- Gynecologic Oncology Reports×3
- SSRN Electronic Journal×2
- International Journal of Women s Health×1
- Clinical Practice and Cases in Emergency Medicine×1
- Larry J. Copeland
Medicine · The Ohio State University
- Lisa M. Landrum
Medicine · Indiana University
- Kristin Bixel
Medicine · The Ohio State University
- Corinne Calo
Medicine · The Ohio State University
- Julia Chalif
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile